TrademarkDir
BIOTRONIK CARDIOSPHERE
LIVE

Serial Number

79354246

Owner

BIOTRONIK SE & Co. KG

Attorney

Bryan H. Opalko

Filing Date

Sep 22, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

BIOTRONIK CARDIOSPHERE Trademark

Serial Number: 79354246 • Registration: 7470080

BIOTRONIK CARDIOSPHERE is a trademark filed by BIOTRONIK SE & Co. KG on September 22, 2022. The trademark is classified under Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

BIOTRONIK SE & Co. KG (2 trademarks)

Woermannkehre 1
Berlin 12359 , DE

Entity Type: 99

Trademark Details

Filing Date

September 22, 2022

Registration Date

August 13, 2024

Published for Opposition

May 28, 2024

Goods & Services

Advertising goods and services on online websites; Advertising, marketing and promotional services for advertising, marketing and promoting exhibition events; Data processing services related to retrieval of medical information data

Medical information services provided via the Internet; Information services concerning medical products, namely, providing medical information to healthcare professionals in the field of cardiology; Provision of information relating to medical services, namely, providing medical information; Providing health, medical, and medical treatment information in the field of cardiology to physicians, healthcare professionals and patients; Providing online health, medical, and medical treatment information in the field of medical devices, namely, cardiological devices

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 22, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 1, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 1, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 13, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 13, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 13, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Jun 11, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 15, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 15, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 23, 2024 CNSA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 22, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 3, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 3, 2024 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 26, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 10, 2024 GNFN
FINAL REFUSAL E-MAILED
Jan 10, 2024 GNFR
FINAL REFUSAL WRITTEN
Jan 10, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 13, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 13, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 24, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 24, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 24, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 24, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 24, 2023 COAR
REFUSAL PROCESSED BY IB
Sep 12, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 24, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 24, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 2, 2023 RFCR
NON-FINAL ACTION WRITTEN
Aug 1, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 12, 2023 DOCK
ASSIGNED TO EXAMINER
Jul 6, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 8, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 3, 2022 REPR

Related Trademarks

More from this Owner

ZENACOR

ZENACOR

PROACTIVE INTELLIGENCE

PROACTIVE INTELLIGENCE

BIOT logo

BIOT

BIOTRONIK ATLAS

BIOTRONIK ATLAS

BIOTRONIK ATLAS

BIOTRONIK ATLAS

BIOEXPRESS

BIOEXPRESS